BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 2494158)

  • 1. Long-term use of valproate in primary psychiatric disorders.
    Hayes SG
    J Clin Psychiatry; 1989 Mar; 50 Suppl():35-9. PubMed ID: 2494158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment guidelines for valproate in bipolar and schizoaffective disorders.
    McElroy SL; Keck PE
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S62-6. PubMed ID: 8500081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR; Fawcett J; Zajecka JM
    J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
    Tohen M; Castillo J; Pope HG; Herbstein J
    J Clin Psychopharmacol; 1994 Feb; 14(1):67-70. PubMed ID: 8151006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
    Jacobsen FM
    J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate.
    Sokolski KN; Denson TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):863-6. PubMed ID: 12921920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is clozapine a mood stabilizer?
    Zarate CA; Tohen M; Banov MD; Weiss MK; Cole JO
    J Clin Psychiatry; 1995 Mar; 56(3):108-12. PubMed ID: 7883728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.
    Banov MD; Zarate CA; Tohen M; Scialabba D; Wines JD; Kolbrener M; Kim JW; Cole JO
    J Clin Psychiatry; 1994 Jul; 55(7):295-300. PubMed ID: 8071290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E; Goikolea JM; Corbella B; Benabarre A; Reinares M; Martínez G; Fernández A; Colom F; Martínez-Arán A; Torrent C;
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid cycling bipolar disorder and its treatment with valproate.
    Calabrese JR; Rapport DJ; Kimmel SE; Reece B; Woyshville MJ
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S57-61. PubMed ID: 8500080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Valproate in the treatment of bipolar disorder].
    Rzewuska M
    Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine in treatment-refractory mood disorders.
    Kimmel SE; Calabrese JR; Woyshville MJ; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():91-3. PubMed ID: 7961583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project.
    Kauer-Sant'Anna M; Bond DJ; Lam RW; Yatham LN
    Compr Psychiatry; 2009; 50(1):1-8. PubMed ID: 19059506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
    Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
    Keck PE; McElroy SL
    J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate in psychiatric disorders: literature review and clinical guidelines.
    McElroy SL; Keck PE; Pope HG; Hudson JI
    J Clin Psychiatry; 1989 Mar; 50 Suppl():23-9. PubMed ID: 2494155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging perspectives on valproate in affective disorders.
    Post RM
    J Clin Psychiatry; 1989 Mar; 50 Suppl():3-9. PubMed ID: 2494156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.